Viral Infections

INTELENCE (etravirine) 200mg tablets by Tibotec

Intelence 200mg dosage strength approved

The FDA has approved a 200mg dosage strength of Intelence (etravirine tablets, from Tibotec), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated for the treatment of HIV-1 in treatment-experienced adults with resistance to an NNRTI and other antiretroviral agents.